000182103 001__ 182103
000182103 005__ 20241228120953.0
000182103 0247_ $$2doi$$a10.1007/s00432-022-04407-1
000182103 0247_ $$2pmid$$apmid:36241862
000182103 0247_ $$2ISSN$$a0084-5353
000182103 0247_ $$2ISSN$$a0171-5216
000182103 0247_ $$2ISSN$$a0943-9382
000182103 0247_ $$2ISSN$$a1432-1335
000182103 0247_ $$2altmetric$$aaltmetric:137291705
000182103 037__ $$aDKFZ-2022-02421
000182103 041__ $$aEnglish
000182103 082__ $$a610
000182103 1001_ $$0P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aArndt, Volker$$b0$$eFirst author$$udkfz
000182103 245__ $$aCancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic.
000182103 260__ $$aBerlin$$bSpringer$$c2023
000182103 264_1 $$2Crossref$$3online$$bSpringer Science and Business Media LLC$$c2022-10-14
000182103 264_1 $$2Crossref$$3print$$bSpringer Science and Business Media LLC$$c2023-02-01
000182103 264_1 $$2Crossref$$3print$$bSpringer Science and Business Media LLC$$c2023-02-01
000182103 3367_ $$2DRIVER$$aarticle
000182103 3367_ $$2DataCite$$aOutput Types/Journal article
000182103 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1676991683_21827
000182103 3367_ $$2BibTeX$$aARTICLE
000182103 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000182103 3367_ $$00$$2EndNote$$aJournal Article
000182103 500__ $$a#EA:C071#EA:C070#LA:E220# / 2023 Feb;149(2):913-919
000182103 520__ $$aAn increasing number of international studies demonstrate serious negative effects of the COVID-19 pandemic on the timely diagnosis of cancer and on cancer treatment. Our study aimed to quantitatively and qualitatively evaluate the capacities of German Comprehensive Cancer Centers (CCCs) in different areas of complex oncology care during the first 2 years of the COVID-19 pandemic.Prospective panel survey over 23 rounds among 18 CCCs in Germany between March 2020 and June 2022.The COVID-19 pandemic substantially affected the oncological care system in Germany during the first 2 years. Persistent limitations of care in CCCs primarily affected follow-up (- 21%) and psycho-oncologic care (- 12%), but also tumor surgery (- 9%). Substantial limitations were also reported for all other areas of multidisciplinary oncological care.This study documents the limitations of oncological care during the COVID-19 pandemic and highlights the need to develop strategies to avoid similar limitations in the future.
000182103 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000182103 542__ $$2Crossref$$i2022-10-14$$uhttps://creativecommons.org/licenses/by/4.0
000182103 542__ $$2Crossref$$i2022-10-14$$uhttps://creativecommons.org/licenses/by/4.0
000182103 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000182103 650_7 $$2Other$$aAftercare
000182103 650_7 $$2Other$$aComprehensive cancer centers
000182103 650_7 $$2Other$$aEarly diagnosis of cancer
000182103 650_7 $$2Other$$aSARS-CoV-2 infection
000182103 650_7 $$2Other$$aTreatment delays
000182103 7001_ $$0P:(DE-He78)55389e9f54d8411e6e6eddcec489bb1b$$aDoege, Daniela$$b1$$eFirst author$$udkfz
000182103 7001_ $$0P:(DE-He78)f0144d171d26dbedb67c9db1df35629d$$aFröhling, Stefan$$b2$$udkfz
000182103 7001_ $$aAlbers, Peter$$b3
000182103 7001_ $$aAlgül, Hana$$b4
000182103 7001_ $$00000-0002-1221-7421$$aBargou, Ralf$$b5
000182103 7001_ $$00000-0001-6071-7810$$aBokemeyer, Carsten$$b6
000182103 7001_ $$aBornhäuser, Martin$$b7
000182103 7001_ $$00000-0003-1732-2535$$aBrandts, Christian H$$b8
000182103 7001_ $$aBrossart, Peter$$b9
000182103 7001_ $$00000-0001-5162-1542$$aBrucker, Sara Yvonne$$b10
000182103 7001_ $$00000-0002-9677-3723$$aBrümmendorf, Tim H$$b11
000182103 7001_ $$00000-0003-2116-5536$$aDöhner, Hartmut$$b12
000182103 7001_ $$00000-0002-9792-2495$$aGattermann, Norbert$$b13
000182103 7001_ $$00000-0002-7425-4455$$aHallek, Michael$$b14
000182103 7001_ $$00000-0002-1349-3321$$aHeinemann, Volker$$b15
000182103 7001_ $$aKeilholz, Ulrich$$b16
000182103 7001_ $$00000-0002-0383-0507$$aKindler, Thomas$$b17
000182103 7001_ $$avon Levetzow, Cornelia$$b18
000182103 7001_ $$00000-0001-8591-9339$$aLordick, Florian$$b19
000182103 7001_ $$00000-0002-3831-8917$$aNeumann, Ulf Peter$$b20
000182103 7001_ $$aPeters, Christoph$$b21
000182103 7001_ $$00000-0003-3524-7858$$aSchadendorf, Dirk$$b22
000182103 7001_ $$00000-0002-6830-9296$$aStilgenbauer, Stephan$$b23
000182103 7001_ $$00000-0002-4266-6818$$aZander, Thomas$$b24
000182103 7001_ $$00000-0001-5779-9675$$aZips, Daniel$$b25
000182103 7001_ $$0P:(DE-He78)5df998d953f664b5230be9553e48e293$$aBraun, Delia$$b26$$udkfz
000182103 7001_ $$00000-0003-3259-0810$$aSeufferlein, Thomas$$b27
000182103 7001_ $$aNettekoven, Gerd$$b28
000182103 7001_ $$0P:(DE-He78)933f7d725ac87378f459623783585a1f$$aBaumann, Michael$$b29$$eLast author$$udkfz
000182103 77318 $$2Crossref$$3journal-article$$a10.1007/s00432-022-04407-1$$bSpringer Science and Business Media LLC$$d2022-10-14$$n2$$p913-919$$tJournal of Cancer Research and Clinical Oncology$$v149$$x0171-5216$$y2022
000182103 773__ $$0PERI:(DE-600)1459285-X$$a10.1007/s00432-022-04407-1$$n2$$p913-919$$tJournal of cancer research and clinical oncology$$v149$$x0171-5216$$y2022
000182103 8767_ $$8V52536$$92023-12-01$$d2024-12-27$$eHybrid-OA$$jZahlung erfolgt
000182103 909CO $$ooai:inrepo02.dkfz.de:182103$$pVDB$$pOpenAPC$$popenCost
000182103 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000182103 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)55389e9f54d8411e6e6eddcec489bb1b$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000182103 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f0144d171d26dbedb67c9db1df35629d$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000182103 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)5df998d953f664b5230be9553e48e293$$aDeutsches Krebsforschungszentrum$$b26$$kDKFZ
000182103 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)933f7d725ac87378f459623783585a1f$$aDeutsches Krebsforschungszentrum$$b29$$kDKFZ
000182103 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000182103 9141_ $$y2022
000182103 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000182103 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000182103 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-21
000182103 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000182103 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-21
000182103 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000182103 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ CANCER RES CLIN : 2022$$d2023-10-21
000182103 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-21
000182103 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-21
000182103 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-21
000182103 915pc $$0PC:(DE-HGF)0000$$2APC$$aAPC keys set
000182103 915pc $$0PC:(DE-HGF)0001$$2APC$$aLocal Funding
000182103 9202_ $$0I:(DE-He78)E220-20160331$$kE220$$lE220 Radioonkologie Radiobiologie$$x0
000182103 9201_ $$0I:(DE-He78)C071-20160331$$kC071$$lC071 Cancer Survivorship$$x0
000182103 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x1
000182103 9201_ $$0I:(DE-He78)B340-20160331$$kB340$$lTranslationale Medizinische Onkologie$$x2
000182103 9201_ $$0I:(DE-He78)E220-20160331$$kE220$$lE220 Radioonkologie Radiobiologie$$x3
000182103 9200_ $$0I:(DE-He78)C071-20160331$$kC071$$lC071 Cancer Survivorship$$x0
000182103 9200_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x1
000182103 980__ $$ajournal
000182103 980__ $$aVDB
000182103 980__ $$aI:(DE-He78)C071-20160331
000182103 980__ $$aI:(DE-He78)C070-20160331
000182103 980__ $$aI:(DE-He78)B340-20160331
000182103 980__ $$aI:(DE-He78)E220-20160331
000182103 980__ $$aUNRESTRICTED
000182103 980__ $$aAPC
000182103 999C5 $$1M Aapro$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.esmoop.2020.100038$$p100038 -$$tESMO Open$$uAapro M, Lyman GH, Bokemeyer C, Rapoport BL, Mathieson N, Koptelova N, Cornes P, Anderson R, Gascon P, Kuderer NM (2021) Supportive care in patients with cancer during the COVID-19 pandemic. ESMO Open 6:100038. https://doi.org/10.1016/j.esmoop.2020.100038$$v6$$y2021
000182103 999C5 $$1AG Dinmohamed$$2Crossref$$9-- missing cx lookup --$$a10.1186/s13045-020-00984-1$$p147 -$$tJ Hematol Oncol$$uDinmohamed AG, Cellamare M, Visser O, de Munck L, Elferink MAG, Westenend PJ, Wesseling J, Broeders MJM, Kuipers EJ, Merkx MAW, Nagtegaal ID, Siesling S (2020a) The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands. J Hematol Oncol 13:147. https://doi.org/10.1186/s13045-020-00984-1$$v13$$y2020
000182103 999C5 $$1AG Dinmohamed$$2Crossref$$9-- missing cx lookup --$$a10.1016/S1470-2045(20)30265-5$$p750 -$$tLancet Oncol$$uDinmohamed AG, Visser O, Verhoeven RHA, Louwman MWJ, van Nederveen FH, Willems SM, Merkx MAW, Lemmens V, Nagtegaal ID, Siesling S (2020b) Fewer cancer diagnoses during the COVID-19 epidemic in The Netherlands. Lancet Oncol 21:750–751. https://doi.org/10.1016/S1470-2045(20)30265-5$$v21$$y2020
000182103 999C5 $$1F Erdmann$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.lanepe.2021.100188$$tLancet Reg Health Eur$$uErdmann F, Wellbrock M, Trubenbach C, Spix C, Schrappe M, Schuz J, Grabow D, Eichinger M (2021) Impact of the COVID-19 pandemic on incidence, time of diagnosis and delivery of healthcare among paediatric oncology patients in Germany in 2020: evidence from the German Childhood Cancer Registry and a qualitative survey. Lancet Reg Health Eur 9:100188. https://doi.org/10.1016/j.lanepe.2021.100188$$v9$$y2021
000182103 999C5 $$1ML Gasparri$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.breast.2020.05.006$$p110 -$$tBreast$$uGasparri ML, Gentilini OD, Lueftner D, Kuehn T, Kaidar-Person O, Poortmans P (2020) Changes in breast cancer management during the Corona Virus Disease 19 pandemic: an international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST). Breast 52:110–115. https://doi.org/10.1016/j.breast.2020.05.006$$v52$$y2020
000182103 999C5 $$2Crossref$$uGünster C, Drogan D, Hentschker C, Klauber J, Malzahn J, Schillinger G, Mostert C (2020) WIdO-Report: Entwicklung der Krankenhausfallzahlen während des Coronavirus-Lockdowns. Nach ICD-Diagnosekapiteln und ausgewählten Behandlungsanlässen [WIdO Report: Development of Hospital Case Numbers during the Coronavirus Lockdown. By ICD Diagnosis Chapters and Selected Treatment Causes]. Wissenschaftliches Institut der AOK (WldO) im AOK-Bundesverband GbR, Berlin
000182103 999C5 $$1HW Kaufman$$2Crossref$$9-- missing cx lookup --$$a10.1001/jamanetworkopen.2020.17267$$pe2017267 -$$tJAMA Netw Open$$uKaufman HW, Chen Z, Niles J, Fesko Y (2020) Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic. JAMA Netw Open 3:e2017267. https://doi.org/10.1001/jamanetworkopen.2020.17267$$v3$$y2020
000182103 999C5 $$1HW Kaufman$$2Crossref$$9-- missing cx lookup --$$a10.1200/CCI.21.00074$$p1028 -$$tJCO Clin Cancer Inform$$uKaufman HW, Chen Z, Niles JK, Radcliff J, Fesko Y (2021) Patterns of prostate-specific antigen testing and prostate biopsies during the COVID-19 pandemic. JCO Clin Cancer Inform 5:1028–1033. https://doi.org/10.1200/CCI.21.00074$$v5$$y2021
000182103 999C5 $$1J Kleemann$$2Crossref$$9-- missing cx lookup --$$a10.1111/jdv.18217$$p1766 -$$tJ Eur Acad Dermatol Venereol$$uKleemann J, Meissner M, Ozistanbullu D, Balaban U, Old O, Kippenberger S, Kloka J, Kaufmann R, Zacharowski K, Friedrichson B (2022) Impact of the Covid-19 pandemic on melanoma and non-melanoma skin cancer inpatient treatment in Germany—a nationwide analysis. J Eur Acad Dermatol Venereol 36:1766–1773. https://doi.org/10.1111/jdv.18217$$v36$$y2022
000182103 999C5 $$1F Klein$$2Crossref$$9-- missing cx lookup --$$a10.1007/s15015-018-3998-7$$p81 -$$tIm Focus Onkol$$uKlein F (2018) Netzwerk Onkologische Spitzenzentren—Vernetzung für eine bessere Patientenversorgung [Network of oncology centers of excellence—networking for better patient care]. Im Focus Onkol 21:81–83$$v21$$y2018
000182103 999C5 $$1M Maluchnik$$2Crossref$$9-- missing cx lookup --$$a10.1080/0284186X.2020.1837392$$p28 -$$tActa Oncol$$uMaluchnik M, Podwojcic K, Wieckowska B (2021) Decreasing access to cancer diagnosis and treatment during the COVID-19 pandemic in Poland. Acta Oncol 60:28–31. https://doi.org/10.1080/0284186X.2020.1837392$$v60$$y2021
000182103 999C5 $$1C Maringe$$2Crossref$$9-- missing cx lookup --$$a10.1016/s1470-2045(20)30388-0$$p1023 -$$tLancet Oncol$$uMaringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R, Rachet B, Aggarwal A (2020) The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol 21:1023–1034. https://doi.org/10.1016/s1470-2045(20)30388-0$$v21$$y2020
000182103 999C5 $$1NP Marques$$2Crossref$$9-- missing cx lookup --$$a10.1053/j.seminoncol.2020.12.002$$p156 -$$tSemin Oncol$$uMarques NP, Silveira DMM, Marques NCT, Martelli DRB, Oliveira EA, Martelli-Junior H (2021) Cancer diagnosis in Brazil in the COVID-19 era. Semin Oncol 48:156–159. https://doi.org/10.1053/j.seminoncol.2020.12.002$$v48$$y2021
000182103 999C5 $$1C Mathelin$$2Crossref$$9-- missing cx lookup --$$a10.4274/ejbh.galenos.2021.2021-1-4$$p188 -$$tEur J Breast Health$$uMathelin C, Ame S, Anyanwu S, Avisar E, Boubnider WM, Breitling K, Anie HA, Conceicao JC, Dupont V, Elder E, Elfgen C, Elonge T, Iglesias E, Imoto S, Ioannidou-Mouzaka L, Kappos EA, Kaufmann M, Knauer M, Luzuy F, Margaritoni M, Mbodj M, Mundinger A, Orda R, Ostapenko V, Ozbas S, Ozmen V, Pagani O, Pienkowski T, Schneebaum S, Shmalts E, Selim A, Pavel Z, Lodi M, Maghales-Costa M (2021) Breast cancer management during the COVID-19 pandemic: the senologic international society survey. Eur J Breast Health 17:188–196. https://doi.org/10.4274/ejbh.galenos.2021.2021-1-4$$v17$$y2021
000182103 999C5 $$1M Richards$$2Crossref$$9-- missing cx lookup --$$a10.1038/s43018-020-0074-y$$p565 -$$tNat Cancer$$uRichards M, Anderson M, Carter P, Ebert BL, Mossialos E (2020) The impact of the COVID-19 pandemic on cancer care. Nat Cancer 1:565–567. https://doi.org/10.1038/s43018-020-0074-y$$v1$$y2020
000182103 999C5 $$2Crossref$$uRobert Koch-Institute (2022a) COVID-19-Hospitalisierungen in Deutschland [COVID-19 hospitalizations in Germany]. https://github.com/robert-koch-institut/COVID-19-Hospitalisierungen_in_Deutschland. Accessed 22 Sept 2022a
000182103 999C5 $$2Crossref$$uRobert Koch-Institute (2022b) Gesamtübersicht der pro Tag ans RKI übermittelten Fälle und Todesfälle [General survey of cases and deaths transmitted to the RKI per day]. https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Daten/Fallzahlen_Gesamtuebersicht.xlsx. Accessed 23 June 2022b
000182103 999C5 $$2Crossref$$uRobert Koch-Institute, DIVI e.V. (2022) DIVI-Intensivregister [DIVI Intensive Care Registry] https://www.intensivregister.de/#/aktuelle-lage/downloads. Accessed 23 June 2022
000182103 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1007/978-3-662-64685-4_6$$uRückher J, Mangiapane S, Seufferlein T, Pflüger M, Wesselmann S (2022) Auswirkungen der Covid-19-Pandemie auf die onkologische Versorgung [Impact of the covid 19 pandemic on oncology care]. In: Klauber J, Wasem J, Beivers A, Mostert C (eds) Krankenhaus-Report 2022 [Hospital Report 2022]. Springer, Berlin
000182103 999C5 $$1CW Skovlund$$2Crossref$$9-- missing cx lookup --$$a10.1080/0284186X.2020.1858235$$p20 -$$tActa Oncol$$uSkovlund CW, Friis S, Dehlendorff C, Nilbert MC, Morch LS (2021) Hidden morbidities: drop in cancer diagnoses during the COVID-19 pandemic in Denmark. Acta Oncol 60:20–23. https://doi.org/10.1080/0284186X.2020.1858235$$v60$$y2021
000182103 999C5 $$1S Voigtlander$$2Crossref$$9-- missing cx lookup --$$a10.3238/arztebl.m2021.0329$$p660 -$$tDtsch Arztebl Int$$uVoigtlander S, Hakimhashemi A, Inwald EC, Ortmann O, Gerken M, Klug SJ, Klinkhammer-Schalke M, Meyer M, Muller-Nordhorn J (2021) The impact of the COVID-19 pandemic on cancer incidence and treatment by cancer stage in Bavaria, Germany. Dtsch Arztebl Int 118:660–661. https://doi.org/10.3238/arztebl.m2021.0329$$v118$$y2021
000182103 999C5 $$1KC Weisel$$2Crossref$$9-- missing cx lookup --$$a10.1159/000508272$$p307 -$$tOncol Res Treat$$uWeisel KC, Morgner-Miehlke A, Petersen C, Fiedler W, Block A, Schafhausen P, Knobloch JK, Bokemeyer C (2020) Implications of SARS-CoV-2 infection and COVID-19 crisis on clinical cancer care: report of the university cancer center Hamburg. Oncol Res Treat 43:307–313. https://doi.org/10.1159/000508272$$v43$$y2020
000182103 999C5 $$2Crossref$$uWorld Health Organization (2020) COVID-19 significantly impacts health services for noncommunicable diseases. https://www.who.int/news/item/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseases. Accessed 17 June 2022